Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy

Prof. Scott T. Tagawa

Medical Director, Genitourinary Oncology Research Program, Weill Cornell Medical College, New York, USA